Biotechnology occasionally delivers moments that redefine what medicine can achieve. One of those moments has just taken place in Philadelphia, where a newborn with a fatal metabolic disorder became the first patient to receive a personalized CRISPR therapy—developed and delivered in less than six months. From Diagnosis to Cure in Record Time The infant, diagnosed…